STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT00478465
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2017-11-29
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 10
- Registration Number
- NCT00477087
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Ethnic Dance and Screen Time Reduction to Prevent Weight Gain in Latina Girls
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2012-12-17
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 233
- Registration Number
- NCT00476775
- Locations
- 🇺🇸
Stanford Prevention Research Center, Stanford, California, United States
Fulvestrant in Hormone Refractory Prostate Cancer
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 10
- Registration Number
- NCT00476645
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer
Completed
- Conditions
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2011-04-13
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 4
- Registration Number
- NCT00477139
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Citalopram in Irritable Bowel Syndrome
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 54
- Registration Number
- NCT00477165
- Locations
- 🇺🇸
UCSF, San Francisco, California, United States
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
Phase 1
Terminated
- Conditions
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2012-05-28
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 18
- Registration Number
- NCT00473005
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Geodon in Weight Loss Study for Bipolar Disorders
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 25
- Registration Number
- NCT00472641
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application
Not Applicable
Withdrawn
- Conditions
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2013-06-13
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00466570
Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Not Applicable
Terminated
- Conditions
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00466713
- Locations
- 🇺🇸
Stanford University Hospital, Stanford, California, United States
© Copyright 2024. All Rights Reserved by MedPath